NGSX- the patch was approved by the FDA for the management of neuropathic pain due to postherpetic neuralgia. <a href="http://finance.yahoo.com/news/NeurogesX-shares-rise-apf-3040400066.html?x=0&.v=3" rel="nofollow" target="_blank">http://finance.yahoo.com/news/NeurogesX-shares-rise-apf-3040400066.html?x=0&.v=3</a>